The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling

JAMA Neurology

Volumn 73, Issue 7, 2016, Pages 860-866

  Kolb, Noah A ^a   Smith, A Gordon ^a   Singleton, J Robinson ^a   Beck, Susan L ^b   Stoddard, Gregory J ^a   Brown, Summer ^a   Mooney, Kathi ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM DERIVATIVE; TAXANE DERIVATIVE; ANTINEOPLASTIC AGENT; BRIDGED COMPOUND; PLATINUM; TAXANE; TAXOID;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FALL RISK; FALLING; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVARY CANCER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; AGED; BREAST NEOPLASMS; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; LUNG NEOPLASMS; MIDDLE AGED; OVARIAN NEOPLASMS; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA;

ACCIDENTAL FALLS; ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BRIDGED-RING COMPOUNDS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OVARIAN NEOPLASMS; PERIPHERAL NERVOUS SYSTEM DISEASES; PLATINUM; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TAXOIDS;

EID: 84978062965     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2016.0383     Document Type: Article

References (28)

1. Won HH, Lee J, Park JO, et al. Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients. Cancer. 2012;118(11):2828-2836. doi:10.1002/cncr.26614.
2. Raymond E, Chaney SG, Taamma A, Cvitkovic E. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol. 1998;9(10):1053-1071.
3. Hertz DL, Roy S, Motsinger-Reif AA, et al. CYP2C83 increases risk of neuropathy in breast cancer patients treated with paclitaxel. Ann Oncol. 2013;24(6):1472-1478.
4. Ward PR,Wong MD, Moore R, Naeim A. Fall-related injuries in elderly cancer patients treated with neurotoxic chemotherapy: a retrospective cohort study. J Geriatr Oncol. 2014;5 (1):57-64.
5. Pachman DR, Barton DL,Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther. 2011;90(3):377-387.
6. Vellas BJ,Wayne SJ, Romero LJ, Baumgartner RN, Garry PJ. Fear of falling and restriction of mobility in elderly fallers. Age Ageing. 1997;26(3): 189-193.
7. LaPointe NE, Morfini G, Brady ST, Feinstein SC, Wilson L, Jordan MA. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy. Neurotoxicology. 2013;37:231-239.
8. Windebank AJ, GrisoldW. Chemotherapyinduced neuropathy. J Peripher Nerv Syst. 2008;13 (1):27-46.
9. Quasthoff S, Hartung HP. Chemotherapyinduced peripheral neuropathy. J Neurol. 2002;249 (1):9-17.
10. Tofthagen C, Donovan KA, Morgan MA, Shibata D, Yeh Y. Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors. Support Care Cancer. 2013;21(2):3307-3313.
11. Stone CA, Lawlor PG, Kenny RA. How to identify patients with cancer at risk of falling: a review of the evidence. J Palliat Med. 2011;14(2):221-230.
12. Gewandter JS, Fan L, Magnuson A, et al. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013;21(7):2059-2066.
13. Mooney KH, Beck SL, Friedman RH, Farzanfar R. Telephone-linked care for cancer symptom monitoring: a pilot study. Cancer Pract. 2002;10(3): 147-154.
14. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol. 2012;82 (1):51-77.
15. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79 (3):340-349.
16. Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol. 2013;31(21):2699-2707.
17. Tofthagen C, Overcash J, Kip K. Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2011;20(3): 583-589.
18. Simoneau GG, Derr JA, Ulbrecht JS, Becker MB, Cavanagh PR. Diabetic sensory neuropathy effect on ankle joint movement perception. Arch Phys Med Rehabil. 1996;77(5):453-460.
19. Richardson JK, Ashton-Miller JA, Lee SG, Jacobs K. Moderate peripheral neuropathy impairs weight transfer and unipedal balance in the elderly. Arch Phys Med Rehabil. 1996;77(11):1152-1156.
20. Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ. Willmy patient fall? JAMA. 2007;297(1):77-86.
21. Richardson JK, Hurvitz EA. Peripheral neuropathy: a true risk factor for falls. J Gerontol A Biol Sci Med Sci. 1995;50(4):M211-M215.
22. Richardson JK. Factors associated with falls in older patients with diffuse polyneuropathy. J Am Geriatr Soc. 2002;50(11):1767-1773.
23. Cavanagh PR, Derr JA, Ulbrecht JS, Maser RE, Orchard TJ. Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabet Med. 1992;9(5):469-474.
24. Rosen T, Mack KA, Noonan RK. Slipping and tripping: fall injuries in adults associated with rugs and carpets. J Inj Violence Res. 2013;5(1):61-69.
25. Pike CT, Birnbaum HG, Muehlenbein CE, Pohl GM, Natale RB. Healthcare costs and workloss burden of patients with chemotherapy-Associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer. Chemother Res Pract. 2012;2012(1):913848.
26. Rubenstein LZ, Josephson KR. The epidemiology of falls and syncope. Clin Geriatr Med. 2002;18(2):141-158.
27. Tofthagen C, Visovsky C, Berry DL. Strength and balance training for adults with peripheral neuropathy and high risk of fall: current evidence and implications for future research. Oncol Nurs Forum. 2012;39(5):E416-E424.
28. El-Khoury F, Cassou B, CharlesMA, Dargent-Molina P. The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-Analysis of randomised controlled trials. BMJ. 2013;347:f6234.